Stomach, Intestines

Industry

CPC
C07K16/3046

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C07Organic chemistry C07KPEPTIDES C07K16/00Immunoglobulins [IGs]

Current Industry

C07K16/3046Stomach, Intestines

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Cleavable tetrazine used in bio-orthogonal drug activation
- Patent number 12,186,405
- Issue date Jan 7, 2025
- Tagworks Pharmaceuticals B.V.
- Marc Stefan Robillard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides and scaffolds thereof for use...
- Patent number 12,180,256
- Issue date Dec 31, 2024
- Immatics Biotechnologies GmbH
- Oliver Schoor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for manipulating phagocytosis mediated by CD47
- Patent number 12,162,939
- Issue date Dec 10, 2024
- The Board of Trustees of the Leland Stanford Junior University
- Siddhartha Jaiswal
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides and combination of peptides and scaffolds thereof for use...
- Patent number 12,150,979
- Issue date Nov 26, 2024
- Immatics Biotechnologies GmbH
- Oliver Schoor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 12,071,458
- Issue date Aug 27, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy involving antibodies against Claudin 18.2 for t...
- Patent number 12,059,464
- Issue date Aug 13, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides for use in immunotherapy against cancers
- Patent number 12,060,400
- Issue date Aug 13, 2024
- Immatics Biotechnologies GmbH
- Colette Song
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies against claudin 18.2 useful in cancer diagnosis
- Patent number 11,976,130
- Issue date May 7, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in...
- Patent number 11,965,031
- Issue date Apr 23, 2024
- Bristol-Myers Squibb Company
- Vladimir Coric
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant monoclonal antibodies and corresponding antigens for co...
- Patent number 11,952,429
- Issue date Apr 9, 2024
- PRECISION BIOLOGICS, INC.
- J. Andrew Bristol
- G01 - MEASURING TESTING
Information Patent Grant
Binding molecules that inhibit cancer growth
- Patent number 11,939,394
- Issue date Mar 26, 2024
- Merus N.V.
- Mark Throsby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 11,912,749
- Issue date Feb 27, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides for use in immunotherapy again...
- Patent number 11,912,748
- Issue date Feb 27, 2024
- Immatics Biotechnologies GmbH
- Andrea Mahr
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-mesothelin binding proteins
- Patent number 11,866,508
- Issue date Jan 9, 2024
- Amgen Inc.
- William Christian Fanslow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cancer stem cell-specific molecule
- Patent number 11,858,987
- Issue date Jan 2, 2024
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Tatsumi Yamazaki
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating cancer comprising administration of anti-HER2 a...
- Patent number 11,795,236
- Issue date Oct 24, 2023
- Daiichi Sankyo Company, Limited
- Hiroyuki Naito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ErbB3 antibodies and uses thereof
- Patent number 11,771,762
- Issue date Oct 3, 2023
- REGENERON PHARMACEUTICALS, INC.
- Christopher Daly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against Claudin-18 for treatment of cancer
- Patent number 11,739,139
- Issue date Aug 29, 2023
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides for use in immunotherapy against cancers
- Patent number 11,685,769
- Issue date Jun 27, 2023
- Immatics Biotechnologies GmbH
- Colette Song
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant fusion proteins targeting CD47 and PD-L1, preparation a...
- Patent number 11,672,859
- Issue date Jun 13, 2023
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Wenzhi Tian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Monoclonal antibody anti-FGFR4
- Patent number 11,643,467
- Issue date May 9, 2023
- EXIRIS S.R.L.
- Paola Gallinari
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody constructs and methods of treating cancer
- Patent number 11,623,953
- Issue date Apr 11, 2023
- Caerus Therapeutics, Inc.
- J. Michael Pierce
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cleavable tetrazine used in bio-orthogonal drug activation
- Patent number 11,617,799
- Issue date Apr 4, 2023
- TAGWORKS PHARMACEUTICALS B.V.
- Marc Stefan Robillard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy comprising nivolumab and ipilimumab
- Patent number 11,612,654
- Issue date Mar 28, 2023
- Bristol-Myers Squibb Company
- Yong Quan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy of T cell activating bispecific antigen binding...
- Patent number 11,613,587
- Issue date Mar 28, 2023
- HOFFMANN-LA ROCHE INC.
- Christian Klein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptides and combination of peptides and scaffolds thereof for use...
- Patent number 11,597,752
- Issue date Mar 7, 2023
- Immatics Biotechnologies GmbH
- Oliver Schoor
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 11,591,392
- Issue date Feb 28, 2023
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- G01 - MEASURING TESTING
Information Patent Grant
Method of treating cancer comprising administration of anti-HER2 an...
- Patent number 11,584,800
- Issue date Feb 21, 2023
- Daiichi Sankyo Company, Limited
- Hiroyuki Naito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant monoclonal antibodies and corresponding antigens for co...
- Patent number 11,572,413
- Issue date Feb 7, 2023
- PRECISION BIOLOGICS, INC.
- Myron Arlen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for...
- Patent number 11,566,076
- Issue date Jan 31, 2023
- Five Prime Therapeutics, Inc.
- Brian Wong
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF
- Publication number 20250032633
- Publication date Jan 30, 2025
- SHANGHAI MIRACOGEN INC
- Chaohong HU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
- Publication number 20240425558
- Publication date Dec 26, 2024
- Immatics Biotechnologies GmbH
- Colette SONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398954
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER
- Publication number 20240402181
- Publication date Dec 5, 2024
- Progastrine et Cancers S.À R.L.
- Alexandre Prieur
- G01 - MEASURING TESTING
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240398955
- Publication date Dec 5, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...
- Publication number 20240360235
- Publication date Oct 31, 2024
- Bristol-Myers Squibb Company
- Vladimir CORIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TU...
- Publication number 20240350528
- Publication date Oct 24, 2024
- HiberCell, Inc.
- Nandita Bose
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING MOLECULES THAT INHIBIT CANCER GROWTH
- Publication number 20240343824
- Publication date Oct 17, 2024
- Merus N.V.
- Mark THROSBY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glycan-Interacting Compounds and Methods of Use
- Publication number 20240342279
- Publication date Oct 17, 2024
- Seagen Inc.
- Ana Paula Galvao da Silva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR CO...
- Publication number 20240343825
- Publication date Oct 17, 2024
- PRECISION BIOLOGICS, INC.
- J. Andrew BRISTOL
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...
- Publication number 20240343808
- Publication date Oct 17, 2024
- Novartis AG
- Gordon James Freeman
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...
- Publication number 20240335533
- Publication date Oct 10, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS
- Publication number 20240309108
- Publication date Sep 19, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODY OR FRAGMENT THEREOF, AND METHOD FOR USING SAME
- Publication number 20240270869
- Publication date Aug 15, 2024
- National University Corporation Tokai National Higher Education and Research...
- Tamotsu TAKEUCHI
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AGAINST TIM3 AND USES THEREOF
- Publication number 20240209083
- Publication date Jun 27, 2024
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND...
- Publication number 20240166741
- Publication date May 23, 2024
- Genentech, Inc.
- Jane GROGAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240148873
- Publication date May 9, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...
- Publication number 20240139324
- Publication date May 2, 2024
- IMMUNOMEDICS, INC.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
- Publication number 20240117022
- Publication date Apr 11, 2024
- Astellas Pharma Inc.
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND...
- Publication number 20240091354
- Publication date Mar 21, 2024
- Bristol-Myers Squibb Company
- Vikram SADINENI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
- Publication number 20240084033
- Publication date Mar 14, 2024
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY
- Publication number 20240024437
- Publication date Jan 25, 2024
- Transgene S.A.
- Philippe Slos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 AN...
- Publication number 20240026030
- Publication date Jan 25, 2024
- Daiichi Sankyo Company, Limited
- Hiroyuki NAITO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Glycan-Interacting Compounds and Methods of Use
- Publication number 20240009306
- Publication date Jan 11, 2024
- Seagen Inc.
- Ana Paula Galvao da Silva
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND...
- Publication number 20230416376
- Publication date Dec 28, 2023
- Regeneron Pharmaceuticals, Inc.
- Robert Babb
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TIM3 AND USES THEREOF
- Publication number 20230382992
- Publication date Nov 30, 2023
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIBODIES AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20230303714
- Publication date Sep 28, 2023
- AskGene Pharma Inc.
- Yuefeng Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE
- Publication number 20230287127
- Publication date Sep 14, 2023
- Genentech, Inc.
- Bryan IRVING
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VEGF/DLL4 BINDING AGENTS AND USES THEREOF
- Publication number 20230279101
- Publication date Sep 7, 2023
- MEREO BIOPHARMA 5, INC.
- Austin L. GURNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2
- Publication number 20230270878
- Publication date Aug 31, 2023
- Ganymed Pharmaceuticals GmbH
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY

Stomach, Intestines

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Cleavable tetrazine used in bio-orthogonal drug activation

Peptides and combination of peptides and scaffolds thereof for use...

Methods for manipulating phagocytosis mediated by CD47

Peptides and combination of peptides and scaffolds thereof for use...

Peptides and combination of peptides for use in immunotherapy again...

Combination therapy involving antibodies against Claudin 18.2 for t...

Peptides for use in immunotherapy against cancers

Antibodies against claudin 18.2 useful in cancer diagnosis

Use of anti-PD-1 antibody in combination with anti-CD27 antibody in...

Recombinant monoclonal antibodies and corresponding antigens for co...

Binding molecules that inhibit cancer growth

Peptides and combination of peptides for use in immunotherapy again...

Peptides and combination of peptides for use in immunotherapy again...

Anti-mesothelin binding proteins

Cancer stem cell-specific molecule

Method for treating cancer comprising administration of anti-HER2 a...

Anti-ErbB3 antibodies and uses thereof

Monoclonal antibodies against Claudin-18 for treatment of cancer

Peptides for use in immunotherapy against cancers

Recombinant fusion proteins targeting CD47 and PD-L1, preparation a...

Monoclonal antibody anti-FGFR4

Antibody constructs and methods of treating cancer

Cleavable tetrazine used in bio-orthogonal drug activation

Combination therapy comprising nivolumab and ipilimumab

Combination therapy of T cell activating bispecific antigen binding...

Peptides and combination of peptides and scaffolds thereof for use...

Antibodies against TIM3 and uses thereof

Method of treating cancer comprising administration of anti-HER2 an...

Recombinant monoclonal antibodies and corresponding antigens for co...

Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for...

Patents Applicationslast 30 patents

ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF

PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING GASTRIC CANCER

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TU...

BINDING MOLECULES THAT INHIBIT CANCER GROWTH

Glycan-Interacting Compounds and Methods of Use

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR CO...

ANTIBODY MOLECULES TO PG-L1 AND METHODS OF TREATING CANCER AND INFE...

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR T...

ANTIBODIES AGAINST CLAUDIN 18.2 USEFUL IN CANCER DIAGNOSIS

ANTIBODY OR FRAGMENT THEREOF, AND METHOD FOR USING SAME

ANTIBODIES AGAINST TIM3 AND USES THEREOF

METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EF...

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND...

CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 AN...

Glycan-Interacting Compounds and Methods of Use

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND...

ANTIBODIES AGAINST TIM3 AND USES THEREOF

NOVEL ANTIBODIES AND METHODS FOR MAKING AND USING THE SAME

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

DRUG CONJUGATES COMPRISING ANTIBODIES AGAINST CLAUDIN 18.2